What is Radiomics?
Turning medical images into data
What’s going on at radiomics.bio?
The latest News
Posted October 16th, 2025
News
radiomics.bio and AstraZeneca join forces to explore the potential for an AI model to predict interstitial lung disease related to cancer treatment
Posted January 10th, 2025
Press Release
radiomics.bio Announces New Chairman
Posted January 10th, 2025
Press Release
Paul Mauhin appointed Chief Financial Officer of radiomics.bio, succeeding Mathieu Delvaux
Posted February 29th, 2024
News
From Images to Impact: Radiomics’ Solutions to Challenges in Immunotherapy
Posted September 5th, 2023
News
Pilot project at the Jewish General Hospital aims to accelerate access to new and highly effective treatments for cancer patients
Posted April 7th, 2023
News
Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy
Publications
The latest Papers
Towards texture accurate slice interpolation of medical images using PixelMiner
Quantitative image analysis models are used for medical imaging tasks such as registration, classification…
A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV Infection
Individuals with Down syndrome (DS) are more prone to develop severe respiratory tract infections. Although a RSV infection has a high clinical impact…
Radiomics and Delta-Radiomics Signatures to Predict Response and Survival…
The aim of our study was to determine the potential role of CT-based radiomics in predicting treatment response and survival in patients with advanced NSCLC…
Automatic segmentation of mediastinal pathological lymph nodes with Deep Learning
The importance of accurate manual segmentations as ground truths
Machine Learning to Identify Patients at Risk of Developing New-Onset Atrial Fibrillation after Coronary Artery Bypass
This study aims to get an effective machine learning (ML) prediction model of new-onset postoperative atrial fibrillation (POAF)…
Deep learning based identification of bone scintigraphies containing metastatic bone disease foci
Metastatic bone disease (MBD) is the most common form of metastases, most frequently deriving from prostate cancer.
